Commentary: Novartis CEO says gene therapies promise to upend US health system, pricing structure
May 17, 2019 at 11:42 AM EDT
The current global health system treats chronic diseases with a pay-as-you-go model, spreading costs over months and years. It's unprepared to pay for a surge of new, single-treatment therapies with the potential to provide a lifetime of benefit.